The psychosocial effect of multiple sclerosis: the impact of relapses
- PMID: 17350047
- DOI: 10.1016/j.jns.2007.01.059
The psychosocial effect of multiple sclerosis: the impact of relapses
Abstract
Historically, the disease course of multiple sclerosis (MS) has been generally characterized by steady progression, with unpredictable relapses possibly resulting in remission. There has always been the threat of incomplete recovery during this period. Therefore, each relapse is a powerful reminder of the chronic nature of the disease, with a profound effect on the social sphere of the individual with MS. MS in general, and relapses in particular, strain the coping mechanisms of the individual and his or her family, friends, and vocational network. Recent evidence has shown that disease-modifying therapy reduces the frequency and severity of MS relapses, an important goal of MS management. Nevertheless, it is important for clinicians to be familiar with the widespread psychosocial impact of MS in terms of their patients' social involvement, partnership and family roles, and employment.
Similar articles
-
The emotional and psychological impact of multiple sclerosis relapses.J Neurol Sci. 2007 May 15;256 Suppl 1:S29-33. doi: 10.1016/j.jns.2007.01.061. Epub 2007 Mar 9. J Neurol Sci. 2007. PMID: 17350045 Review.
-
Family caregiver quality of life in multiple sclerosis among Kuwaitis: a controlled study.BMC Health Serv Res. 2008 Oct 7;8:206. doi: 10.1186/1472-6963-8-206. BMC Health Serv Res. 2008. PMID: 18840287 Free PMC article.
-
The natural history of relapses in multiple sclerosis.J Neurol Sci. 2007 May 15;256 Suppl 1:S5-13. doi: 10.1016/j.jns.2007.01.065. Epub 2007 Mar 7. J Neurol Sci. 2007. PMID: 17346747 Review.
-
Relapses matter: the costs & consequences of multiple sclerosis relapses.J Neurol Sci. 2007 May 15;256 Suppl 1:S1-4. doi: 10.1016/j.jns.2007.01.058. Epub 2007 Mar 9. J Neurol Sci. 2007. PMID: 17350044 Review. No abstract available.
-
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.Acta Neurol Scand. 2009 Feb;119(2):126-30. doi: 10.1111/j.1600-0404.2008.01076.x. Epub 2008 Aug 5. Acta Neurol Scand. 2009. PMID: 18684216
Cited by
-
Barriers to quality of life in patients with multiple sclerosis: a qualitative study.BMC Neurol. 2022 May 13;22(1):174. doi: 10.1186/s12883-022-02700-7. BMC Neurol. 2022. PMID: 35562707 Free PMC article.
-
Validity and Reliability of the Persian Version of the PERception de la Scle'rose En Plaques et de ses Pousse'es Questionnaire Evaluating Multiple Sclerosis-related Quality of Life.Int J Prev Med. 2016 Jan 22;7:25. doi: 10.4103/2008-7802.174773. eCollection 2016. Int J Prev Med. 2016. PMID: 26941926 Free PMC article.
-
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.Neurol Sci. 2013 Feb;34(2):197-203. doi: 10.1007/s10072-012-0981-5. Epub 2012 Mar 11. Neurol Sci. 2013. PMID: 22407022
-
Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study.Curr J Neurol. 2023 Apr 4;22(2):82-86. doi: 10.18502/cjn.v22i2.13332. Curr J Neurol. 2023. PMID: 38011388 Free PMC article.
-
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.J Neurol. 2012 May;259(5):898-905. doi: 10.1007/s00415-011-6275-7. Epub 2011 Oct 19. J Neurol. 2012. PMID: 22008873 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources